PATENT CLAIM ANALYSIS

Application Number: 16133553
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "289000"]

Abstract:
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Claim (Index 25):
The method of  claim 20 , wherein the twice daily administration of the combination results in a total daily dose of bupropion that is about 200 mg to about 250 mg.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 97.0
- Lexical Diversity: 1.45455
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15688660', '15695995', '15691549', '15645939', '15691532']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9005242900389193
- 35 USC 102 Novelty (BERT): 0.6954423704718572
- Combined Prediction Score: 0.8800160980822131
- Mean Citation Score: 793.7393319999999
- Max Citation Score: 808.8913
- Similarity Product: 706.5896846301198

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test